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Introduction
Nucleotide excision repair (NER) is a versatile DNA repair system that removes a wide range of helix-distorting DNA lesions from our genome. Many of these DNA lesions, including ultra-violet (UV) light-induced photolesions, as well as lesions inflicted by compounds such as Illudin S and cisplatin potently block transcription [1] [2] [3] .
Transcription-coupled repair (TCR) is a specialized NER sub-pathway that preferentially removes DNA lesions from actively transcribed DNA strands 4 .
The stalling of elongating RNA polymerase II (RNAPIIo) at DNA lesions was proposed to initiate the TCR pathway by triggering the recruitment of the Cockayne syndrome proteins, CSB and CSA, which, in turn, likely recruit the downstream NER machinery to repair these lesions 5 . Even though the precise molecular mechanism of TCR is far from understood, emerging evidence suggests that modulating chromatin structure is an important prerequisite for mounting an efficient cellular response to transcription-blocking DNA lesions [6] [7] [8] [9] [10] .
Packaging of genomic DNA by histone and non-histone proteins into chromatin complicates efficient DNA repair 11 . Even though it could be argued that there is no need for modulating chromatin structure during TCR since chromatin is already rendered permissive to enable transcription 12 , several studies have implicated a role for chromatin-modifying activities associated with TCR-dependent transcription restart in human cells, including histone chaperones FACT and HIRA, and chromatin remodeling factor SNF2H [6] [7] [8] [9] [10] . Furthermore, core TCR protein CSB is an ATPase with the ability to remodel nucleosomes in vitro 13 , which could contribute to TCR in vivo 14 .
Studies in mouse embryonic fibroblasts have revealed that the nucleosomebinding HMGN1 protein has the ability to increase the cellular transcription potential by unfolding higher-order chromatin structure 15 . Interestingly, mouse embryonic fibroblasts deficient in HMGN1 show a decreased repair rate of UV-induced DNA lesions particularly in transcribed genes 16 , suggesting an involvement in modulating chromatin structure during murine TCR. Rather than a specific TCR factor, murine HMGN1 seems to have a more general role in enabling DNA repair in chromatin, since mouse embryonic fibroblasts deficient in HMGN1 show not only defects in the repair of UV-induced lesions 16 , but also in the repair of oxidative DNA lesions 17 , and DNA double-strand breaks 18 .
Most studies addressing the versatile roles of HMGN1 have focused on mouse cells, while our current understanding of the function of HMGN1 in human cells is fairly limited. Although often assumed 5, 12 , experimental evidence showing that HMGN1 has a role in human TCR -similar to its murine counterpart -is lacking. In this study, we established human knockout cells for HMGN1 alone or in combination with HMGN2.
Functional analysis revealed that, in contrast to mouse cells, human HMGN1 and HMGN2 are dispensable for human TCR.
Results

Generation of human HMGN1 knockout cells
Studies in mouse embryonic fibroblasts have revealed a role of HMGN1 in enhancing the repair rate of UV-induced DNA lesions in particular from transcribed genes 16 , suggesting a possible involvement of HMGN1 in murine transcription-coupled repair (TCR). However, whether HMGN1 is involved in human TCR has remained unexplored. To study a potential role of HMGN1 in human cells, we used CRISPR/Cas9-mediated genome editing to generate HMGN1 knock-out (KO) cells.
To this end, we transfected U2OS cells with vectors encoding HMGN1-specific sgRNAs and Cas9 after which clones were isolated and screened ( Figure 1A) .
Western blot analysis using HMGN1-specific antibodies confirmed the knock-out of HMGN1 in two independent clones ( Figure 1A ; clone 2-4 and 2-11). These findings reveal that loss of HMGN1 is viable in human cells and provide a new tool to study the role of HMGN1 in human cells.
Human HMGN1-KO cells are resistant to Illudin S and UV
Elongating RNA polymerase II (RNAPIIo) molecules are unable to efficiently bypass DNA lesions that block transcription, including those inflicted by the sesquiterpene drug Illudin S 2 or by ultra-violet (UV) light, which inflicts photoproducts such as cyclobutane pyrimidine dimers 1 . To overcome the obstacle posed by these DNA lesions, human cells fully depend on TCR to remove these lesions during transcription.
Particularly Illudin S-induced lesions are remove exclusively by TCR 2 . To directly compare our HMGN1-KO cells in the same genetic background with TCR-deficient cells, we used CRISPR/Cas9-mediated genome editing to generate XPA knockout (KO) cells. Western blot analysis confirmed the knockout of XPA ( Figure 1A) .
Moreover, clonogenic survivals assays in which cells were exposed to increasing concentrations of Illudin S (Figure 1B) , or increasing doses of UV-C light (Figure 1C) , confirmed that XPA-KO cells were highly sensitivity to these DNA-damaging agents compared to parental wild-type (WT) cells. In contrast, two independent HMGN1-KO clones, which, were included in parallel, showed no sensitivity to either Illudin S or UV irradiation compared to WT cells (Figure 1B, C) . These findings show that, in contrast to murine cells 16 , loss of HMGN1 in human cells does not cause sensitivity to transcription-blocking DNA damage.
Human HMGN1-KO cells show normal transcription recovery after UV
In addition to sensitivity to transcription-blocking DNA damage, another hallmark of TCR-deficient cells is their inability to restart transcription after UV irradiation 19 . To quantify the ability of our HMGN1-KO cells to restart transcription, we performed recovery of RNA synthesis (RRS) experiments. To this end, we either mock treated or exposed cells to UV-C light (6 J/m 2 ). Nascent transcripts were pulse-labeled for 1 hour with the cell-permeable thymine analogue 5-ethynyl uridine (5-EU). Nascent transcripts containing 5-EU were visualized via Copper-catalyzed click chemistry of an azide-coupled fluorescent dye. Microscopic analysis revealed that WT cells showed a pronounced inhibition of transcription at 3 hours after UV, due to stalling of RNAPII, while significant transcription restart could be detected at 18 hours after UV irradiation ( Figure 1D , E). This transcription restart was completely blocked in TCR-deficient XPA-KO cells due to their inability to clear transcription-blocking UV-induced lesions from the genome (Figure 1D, E) . In contrast, two independent HMGN1-KO clones showed a normal restart of transcription after UV irradiation, suggesting that these cells are not deficient in TCR.
HMGN2 does not compensate for HMGN1 in TCR
Although HMGN1-deficient mouse embryonic fibroblasts are sensitive to UV irradiation 16 , we did not observe this phenotype in human HMGN1-KO cells. It has been reported that HMGN2 can functionally compensate for HMGN1 in murine cells 20 , and we therefore considered that a similar functional redundancy may mask the role of HMGN1 in human TCR. To test this possibility, we generated HMGN1/HMGN2 double knock-out (dKO) cells by CRISPR-Cas9-mediated genome editing. To this end, U2OS cells were co-transfected with vectors encoding sgRNAs targeting both HMGN1 and HMGN2 genes, as well as with a vector encoding the Cas9 protein. Cells were sorted by flow cytometry based on GFP expression encoded on the Cas9 vector, and clones were isolated and screened. Western blot analysis using antibodies specific for human HMGN1 and HMGN2 confirmed the loss of both HMGN proteins in our selected KO clones (Figure 2A ; clones 1-5 and 1-6). Importantly, two independent HMGN1/HMGN2-dKO clones showed a normal transcription restart after UV irradiation in RRS experiments, while XPA-KO cells, included in parallel failed to resume transcription (Figure 2B, C) . Furthermore, both HMGN1/HMGN2-dKO clones were resistant to Illudin S-induced DNA lesions, while CSB-KO cells, which were included as a control, were highly sensitive to transcription-blocking lesions induced by this compound (Figure 2D) . These findings suggest that HMGN2 does not functionally compensate for HMGN1, and that neither HMGN protein is required for TCR in human cells.
Knockdown of HMGN1 or HMGN2 does not cause TCR defects in human cells
Our previous findings using independently generated HMGN1-KO clones (Figure 1) , or HMGN1/HMGN2-dKO clones revealed no signs of TCR deficiency (Figure 2) . To rule out the possibility that these KO cells genetically adapted during their clonal expansion, we decided to employ a more acute way of removing the expression of HMGN proteins. To this end, we employed specific siRNAs to knockdown the expression of the HMGN proteins or XPA as a control. Western blot analysis showed that we achieved efficient knockdown of HMGN1, HMGN2, or XPA within a timecourse of four days ( Figure 3A) . However, as observed in our HMGN-KO cells, the knockdown of either HMGN1, HMGN2, or the combined knockdown of both HMGN proteins did not affect the restart of transcription after UV irradiation in RRS experiments, while knockdown of XPA fully impaired this process (Figure 3B, C) .
These findings suggest that acute knockdown of HMGN proteins, like genetic knockout of HMGN proteins, does not cause a deficiency in human TCR.
Human HMGN1 does not associate with stalled RNAPII and TCR proteins
Stalling of RNAPII at DNA lesions triggers the association of TCR proteins, including CSB, to initiate repair. We decided to monitor the possible association of HMGN1 with TCR proteins using two independent approaches. We first employed irradiation of cells with a pulsed 266 nm UV-C laser on a live-cell imaging set-up in which all glass optics were replaced by quartz optics to allow full UV-C transmission 21 . To monitor recruitment of proteins using this set-up, we stably expressed either GFP-CSB or HMGN1-GFP in the corresponding KO clones (Figure 4A) . While UV-C laser-induced DNA damage readily triggered recruitment of GFP-CSB into locally irradiated regions, we failed to detect recruitment of HMGN1-GFP to sites of UV-C laser-induced DNA damage ( Figure 4A) . Importantly, the GFP-tagged human HMGN1 cDNA we used here, was previously shown to complement the phenotype of murine HMGN1-deficient cells demonstrating its functionality 16 . As an alternative approach, we employed immunoprecipitation under native conditions after UV irradiation using the same cell lines that were used for live-cell imaging. While we could clearly detect a UV-induced association of RNAPIIo after immunoprecipitation of GFP-CSB, we failed to detect the association of endogenous HMGN1 under the same conditions (Figure 4B) . Similarly, immunoprecipitation of GFP-tagged RNAPII from cells stably expressing GFP-RPB1 22 , revealed robust UV-induced interactions with both CSB and CSA (Figure 4C) , demonstrating that our conditions do allow us to detect interactions with TCR proteins after UV irradiation. However, we could not detect an interaction between GFP-RPB1 and endogenous HMGN1 under these conditions (Figure 4C) . Reciprocal immunoprecipitation experiments on HMGN1-GFP also did not show any interactions with CSB, CSA, RNAPIIo, or HMGN2 in unirradiated or UV-irradiated cells ( Figure   5A ). Finally, we immunoprecipitated endogenous RNAPIIo, which strongly interacted with CSB, CSA and the TFIIH complex after UV irradiation ( Figure 5B) . However, while all these interactions with RNAPIIo were abolished in CSB-KO cells (Figure 5B) , in line with the essential role of this protein in TCR, the UV-induced association of these TCR proteins with RNAPIIo was not affected in two independent HMGN1/HMGN2-dKO clones (Figure 5B) . These findings show that human HMGN1 does not interact with DNA damage-stalled RNAPII and associated TCR proteins, and that both HMGN1 and HMGN2 are dispensable for human TCR.
Discussion
Although often inferred, based on studies in mouse embryonic fibroblasts 16 , it is currenly unknown if the nucleosome-binding protein HMGN1 has a role in modulating chromatin structure to enhance transcription-coupled DNA repair (TCR) in human cells. In the current study, we generated human HMGN1 knockout (KO) cells to directly adress this unanswered question. Functional analysis of human HMGN1-KO cells revealed that this nucleosome-binding protein is dispensible for human TCR. Our findings suggest that the role of murine HMGN1 in TCR is not functionally conserved in human cells.
Human HMGN1 and HMGN2 are not involved in TCR
Several key reviews on TCR mention HMGN1 and list this nucleosome-binding protein as a key factor that modulates human TCR 5, 12, 23 . However, it should be emphasized that while HMGN1-deficient mouse embryonic fibroblasts show decreased repair of UV-induced DNA lesions from active genes 16 , a functional role of HMGN1 in human TCR has not been experimentally adressed. Our results show that knockout or knockdown of the HMGN1 gene, either alone or in combination with the related HMGN2 gene, does not impair TCR in human cells. Several functional assays were performed to monitor a functional role in TCR, including clonogenic survival assays after exposure to either Illudin S or UV light, which both trigger transcription-blocking DNA lesions, or recovery of RNA synthesis (RRS) assays, which measure the ability of cells to restart transcription following UV irradiation. While cells knockout for either the XPA and CSB genes, which are essential for TCR, displayed pronounced defects in all these assays, all the HMGN1-KO or HMGN1/2-dKO clones were indistinguishable from wild-type cells. Thus, our results strongly suggest that HMGN1 and HMGN2 are not required for human TCR.
Human HMGN1 does not associate with stalled RNAPIIo or TCR proteins
Immunoprecipitation experiments do not support an association of HMGN1 with DNA damage-stalled RNAPIIo, or with either CSB or CSA in response to UV irradiation.
These findings are in line with our funtional analysis, and strongly suggest that HMGN1 is not part of the TCR complex. Under the same conditions, we could readily detect a strong UV-induced association between RNAPIIo, CSB, CSA and the TFIIH complex, arguing that our exerimental conditions would allow us to detect the association of HMGN1 if it would occur. Nonetheless, we could neither detect endogenous HMGN1 in CSB precipitates, nor could we detect TCR factors in HMGN1-GFP preciptates.
Thus, our interaction experiments do not support an association of HMGN1 with the human TCR complex. Moreover, we show that the association of known TCR factors with DNA damage-stalled RNAPIIo is not affected by the combined loss of the HMGN1 and HMGN2 genes.
Genetic differences between human and murine TCR
Human HMGN1 is a small (100 amino acid) protein with striking sequence conservation (83%) compared to mouse HMGN1 (96 amino acids; Supplemental Figure 1A ). In fact, the sequence conservation between human and mouse HMGN1 (83%) is far greater than that between human HMGN1 and HMGN2 (47%;
Supplemental Figure 1B, C) . However, our findings suggest that human HMGN1 is not required for human TCR, while a previous study reported that UV-induced lesions in transcribed genes are repaired with decreased efficiency in HMGN1-deficient mouse cells 16 . Importantly, the UV-sensitive phenotype of these HMGN1-KO mouse cells could be rescued by re-expression of wild-type human HMGN1, but not by mutants that are either unable to bind to nucleosomes, or unable to unfold chromatin, suggesting that this phenotype is a specific effect of the loss of the HMGN1 gene in mice 16 .
The strong evolutionary similarity (83%) between human and mouse HMGN1
suggest that it is unlikely that the function of HMGN1 between these species is not conserved due to changes at the protein level. However, there are fundamental differences between the organization of TCR in humans compared to mice that are much more likely to underlie these species-specific differences. In humans, the global genome repair (GGR) sub-pathway of NER recognizes and removes UV-induced cyclobutane pyrimidine dimers (CPD) through the DDB2 damage-recognition factor [24] [25] [26] [27] . Indeed, inherited mutations in DDB2 cause a predisposition to develop skin cancer 28 . In contrast, mice are largely deficient in the removal of CPDs by GGR owing to very low expression levels of DDB2 29 , and instead rely on TCR to remove CPDs from their genome during transcription. Consequently, TCR-deficient CSB-/-and CSA-/-mice develop skin cancer 30, 31 due to their inability to repair CPDs, which is not observed in human Cockayne syndrome (CS) patients 32 . Conversely, CS mice do not display strong neurological features 30, 31 , which is a defining hallmark of CS in human patients 32 , further illustrating differences between mice and man when it comes to TCR deficiency. We propose that human cells may not have a need for HMGN1-mediated chromatin modulation to remove CPDs during TCR, because these lesions are targeted by DDB2-mediated GGR. Indeed, several studies have revealed that DDB2 mediates higher-order chromatin unfolding at sites of UV-induced DNA damage 33, 34 similar to what has been proposed for HMGN1 in mouse cells 15 .
In conclusion, our findings strongly suggest that the role of murine HMGN1 in transcription-coupled DNA repair is not conserved in human cells.
Experimental Procedures
Cell lines. All human cells (listed in table 1) were cultured at 37°C in an atmosphere of 5% CO2 in DMEM (Thermo Fisher Scientific) supplemented with penicillin/streptomycin (Sigma) and 10% Fetal bovine serum (FBS; Bodinco BV). Parental U2OS (WT) cells were a gift from Andreas Ladurner 35 . Plasmid constructs. To insert sgRNA sequences targeting HMGN2 into pX458, two oligonucleotides (see tables 3 and 5) were annealed in annealing buffer (100 mM NaCl, 50 mM HEPES; pH 7,4) by boiling for 5 min in water after which the mixture was allowed to cool down to room temperature.
U2OS (FRT) cells containing the Flp-In
Annealed oligonucleotides were inserted into BbsI-digested pX458 plasmid. The Neomycin resistance gene in pcDNA5/FRT/TO-Neo (Addgene #41000) was replaced with a Puromycin resistance gene.
Fragments spanning GFP-N1 (clontech) including the multiple cloning site were inserted into pcDNA5/FRT/TO-puro. The HMGN1 cDNA was inserted as an XhoI / BsrGI fragment into pcDNA5/FRT/TO-Puro-GFP-N1. All sequences were verified by sequencing.
Clonogenic survival assays. Parental and knockout cell lines were trypsinized, seeded at low density and mock-treated or exposed to an increasing dose of UV light (0.5, 1, 2 J/m 2 of UV-C 266 nm) or an increasing dose of Illudin S (Santa cruz; sc-391575) for 72 h (15, 30, 60 , 100 pg/mL). On day 10, the cells were washed with 0.9% NaCl and stained with methylene blue. Colonies of more than 20 cells were scored. Survival experiments were conducted in triplicate and repeated at least three times. 
Immunoprecipitation for
U2OS (FRT) CSB-KO (1-12)
This study U2OS (FRT) CSB-KO (1-12) + GFP-CSB (3) This study U2OS (FRT) HMGN1-KO (1) (2) (3) (4) (5) (6) (7) (8) (9) This study U2OS (FRT) HMGN1-KO (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) This study U2OS (FRT) HMGN1-KO (2) (3) (4) This study U2OS (FRT) HMGN1-KO (2-4) + HMGN1-GFP (9) This study U2OS (FRT) XPA-KO (2) (3) (4) (5) (6) (7) (8) This study U2OS (WT) 35 U2OS (WT) EGFP-RPB1 22 U2OS (WT) HMGN1/HMGN2-dKO (1) (2) (3) (4) (5) This study U2OS (WT) HMGN1/HMGN2-dKO (1) (2) (3) (4) (5) (6) This study 
